The Sun Pharma Advanced Research Company stock has gained 40 percent this year against a 4 percent rise in the benchmark Nifty50Shares of Sun Pharma Advanced Research Company (SPARC) fell 5 percent to hit the lower circuit on April 10 after the Mumbai-based pharma company said it was abandoning the Phase 2 study on Vodobatinib for Parkinson's.The PROSEEK study was a global trial that enrolled 513 ...

Checking inAfter a lukewarm run in 2023, the EIH stock is seeing a lot of interest from domestic institutions and ultra-HNIs of late. The hospitality story remains hot, supported by a narrative of demand growing faster than supply in the medium term.  Besides, ‘premiumization’ is the trend across consumer sectors, and bulls argue that the hotel industry can’t be immune to it. Mutual funds I...

Sandeshkhali Case: Here's a timeline of what has transpired so farSandeshkhali Violence: The small island in the Sundarbans delta in West Bengal’s North 24-Parganas district has been at the centre of BJP-Trinamool politics in the state.After being on the run for over 50 days, Trinamool Congress leader Sheikh Shahjahan, the main accused in the Sandeshkhali case, was arrested on February 29. Shahj...

Delhi HC agrees to hear a challenge to the entry of foreign lawyers in India, A division bench of the HC directed the BCI to file its response to the plea and agreed to list it in April 2024 for a hearing.The Delhi High Court on February 9 issued a notice to the Bar Council of India (BCI) after a bunch of lawyers challenged its decision to allow the entry of foreign lawyers in India.A division ben...

The BRICS grouping has long been distinguished by a consistent failure to live up to its potential. The internal contradictions are crippling: Divergent interests between members make it difficult to develop any shared policies. Brazil, Russia, and South Africa are commodity exporters; India and China are importers. Brazil, India, and South Africa are democracies; Russia and China only pretend to ...